title: Maintaining quality assurance for sonographic nuchal translucency measurement: lessons from the FASTER Trial.
abstract: OBJECTIVE
  To evaluate nuchal translucency measurement quality assurance techniques in a large-scale study.
  
  
  METHODS
  From 1999 to 2001, unselected patients with singleton gestations between 10 + 3 weeks and 13 + 6 weeks were recruited from 15 centers. Sonographic nuchal translucency measurement was performed by trained technicians. Four levels of quality assurance were employed: (1) a standardized protocol utilized by each sonographer; (2) local-image review by a second sonographer; (3) central-image scoring by a single physician; and (4) epidemiological monitoring of all accepted nuchal translucency measurements cross-sectionally and over time.
  
  
  RESULTS
  Detailed quality assessment was available for 37 018 patients. Nuchal translucency measurement was successful in 96.3% of women. Local reviewers rejected 0.8% of images, and the single central physician reviewer rejected a further 2.9%. Multivariate analysis indicated that higher body mass index, earlier gestational age and transvaginal probe use were predictors of failure of nuchal translucency measurement and central image rejection (P = 0.001). Epidemiological monitoring identified a drift in measurements over time.
  
  
  CONCLUSIONS
  Despite initial training and continuous image review, changes in nuchal translucency measurements occur over time. To maintain screening accuracy, ongoing quality assessment is needed.
authors.affiliation: Columbia University, New York, USA.
authors.forename: M E
authors.initials: ME
authors.lastname: D'Alton
authors.forename: J
authors.initials: J
authors.lastname: Cleary-Goldman
authors.forename: G
authors.initials: G
authors.lastname: Lambert-Messerlian
authors.forename: R H
authors.initials: RH
authors.lastname: Ball
authors.forename: D A
authors.initials: DA
authors.lastname: Nyberg
authors.forename: C H
authors.initials: CH
authors.lastname: Comstock
authors.forename: R
authors.initials: R
authors.lastname: Bukowski
authors.forename: R L
authors.initials: RL
authors.lastname: Berkowitz
authors.forename: P
authors.initials: P
authors.lastname: Dar
authors.forename: L
authors.initials: L
authors.lastname: Dugoff
authors.forename: S D
authors.initials: SD
authors.lastname: Craigo
authors.forename: I E
authors.initials: IE
authors.lastname: Timor
authors.forename: S R
authors.initials: SR
authors.lastname: Carr
authors.forename: H M
authors.initials: HM
authors.lastname: Wolfe
authors.forename: K
authors.initials: K
authors.lastname: Dukes
authors.forename: J A
authors.initials: JA
authors.lastname: Canick
authors.forename: F D
authors.initials: FD
authors.lastname: Malone
mesh_terms: D000328:Adult; D004314:Down Syndrome / Q000000981:diagnostic imaging*; D005260:Female; D006801:Humans; D008403:Mass Screening; D048208:Nuchal Translucency Measurement / Q000592:standards*; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011262:Pregnancy Trimester, Second; D011785:Quality Assurance, Health Care / Q000379:methods*; D055815:Young Adult